This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Lack of expected normal physiological development
R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1091 |
4. Check minimum number of eventsNone |
1091 |
5. Include endpoints |
1091 |
6. Filter based on genotype QC (FinnGen only) |
1091 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Absentia progressus physiologici normalis exspectati
Similar endpoints
↥List of similar endpoints to
Lack of expected normal physiological development
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1091 | 564 | 527 |
| Unadjusted period prevalence (%) | 0.21 | 0.19 | 0.23 |
| Median age at first event (years) | 3.50 | 3.86 | 3.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 726
- Matched controls
- 6962
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
+∞
323.0
326
*
R62.0
ICD-10 Finland
Delayed milestone
933.0
323.0
395
9
R56.8
ICD-10 Finland
Other and unspecified convulsions
845.5
80.8
79
*
F83
ICD-10 Finland
Mixed specific developmental disorders
18.5
69.7
111
67
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.7
53.9
116
134
Z3226
NOMESCO Finland
Physiotherapist
4.6
51.2
211
573
XA800
NOMESCO Finland
Neuropsychological investigation
10.9
47.5
95
95
R50.9
ICD-10 Finland
Fever, unspecified
6.6
47.0
131
224
F80.1
ICD-10 Finland
Expressive language disorder
17.0
45.5
74
46
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.1
44.9
134
250
F82
ICD-10 Finland
Specific developmental disorder of motor function
15.3
43.7
74
51
Z2446
NOMESCO Finland
Social worker
5.0
43.1
155
359
R4110
NOMESCO Finland
Physiotherapy
4.0
42.2
196
583
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.4
41.6
172
458
Z2445
NOMESCO Finland
Psychologist
5.0
40.3
144
329
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
40.2
241
880
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
12.5
37.4
69
58
Z3231
NOMESCO Finland
Registered nurse
3.1
37.2
272
1134
Z2221
NOMESCO Finland
Medical doctor
3.3
37.2
229
844
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
17.5
36.9
59
35
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
36.5
271
1140
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
9.0
35.1
77
90
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
34.2
180
582
RL140
NOMESCO Finland
NA
39.7
34.0
43
11
RT150
NOMESCO Finland
NA
27.6
33.4
46
17
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
+∞
33.0
32
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
32.4
106
217
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
26.3
31.5
44
17
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
27.3
31.1
43
16
Z3229
NOMESCO Finland
Other healthcare associate professional
5.3
30.9
101
206
H01AC01
ATC
somatropin; parenteral
12.0
30.0
56
48
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.1
29.9
86
150
XF400
NOMESCO Finland
ECG with 12 standard connections
3.9
28.8
133
382
602
Kela drug reimbursment
Children's severe malnutrition
11.6
28.0
53
47
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
27.9
152
498
N03AG01
ATC
valproic acid; systemic, rectal
7.8
27.7
66
88
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.0
27.1
93
200
G40.9
ICD-10 Finland
Epilepsy, unspecified
18.8
26.6
41
22
Z31.5
ICD-10 Finland
Genetic counselling
5.2
26.4
86
174
R1260
NOMESCO Finland
Evaluation of communicative skills
24.8
26.2
37
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
24.9
130
410
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.1
24.8
83
173
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
24.7
122
368
N03AF02
ATC
oxcarbazepine; oral
15.3
24.7
41
27
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
23.4
24.4
35
15
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
15.5
24.2
40
26
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
11.1
24.0
46
42
F80.2
ICD-10 Finland
Receptive language disorder
10.2
23.9
48
48
R4120
NOMESCO Finland
Occupational therapy
6.9
23.8
61
91
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.2
23.8
59
84
TPH07
NOMESCO Finland
Cathetrisation of artery
6.1
23.7
67
114
ZXE00
NOMESCO Finland
One hour or less
2.4
23.7
286
1504
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
23.5
203
890
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
22.6
116
360
E34.35
ICD-10 Finland
Abnormal growth retardation
8.3
22.5
51
63
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
22.1
173
714
N03AX14
ATC
levetiracetam; systemic
15.0
21.6
36
24
R51.80
ICD-10 Finland
Headache
3.9
21.6
96
264
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
21.3
135
486
101
Kela drug reimbursment
Anterior pituitary hypofunction
12.7
21.3
38
30
N05BA01
ATC
diazepam; systemic, rectal
5.6
20.9
63
116
N05CD08
ATC
midazolam; nasal, systemic
23.0
20.9
30
13
R55
ICD-10 Finland
Syncope and collapse
11.9
20.6
38
32
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.9
19.7
85
227
R56.0
ICD-10 Finland
Febrile convulsions
+∞
19.6
19
*
Z50.5
ICD-10 Finland
Speech therapy
5.5
19.4
59
110
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.5
19.1
71
165
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.6
19.0
45
60
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.2
18.7
60
119
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
14.7
18.6
31
21
FM2CE
NOMESCO Finland
NA
5.2
18.4
59
117
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
98.4
18.3
20
*
RT490
NOMESCO Finland
NA
37.9
18.3
23
6
RT160
NOMESCO Finland
NA
14.0
18.2
31
22
ZXD20
NOMESCO Finland
Day surgery
3.4
17.6
92
288
N05AX08
ATC
risperidone; systemic
4.1
17.5
70
175
H50.31
ICD-10 Finland
Intermittent exotropia
7.1
17.4
43
61
N05BA09
ATC
clobazam; oral
19.8
17.4
26
13
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
17.3
97
319
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
17.3
34
33
H02AB09
ATC
hydrocortisone; systemic
6.6
17.3
45
69
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.7
17.3
35
36
WX882
NOMESCO Finland
High dependency care
4.8
17.2
59
126
H50.30
ICD-10 Finland
Intermittent esotropy
11.4
17.2
32
28
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
13.1
16.6
29
22
P85
ICPC
Mental retardation
25.2
16.6
23
9
RD210
NOMESCO Finland
NA
4.6
16.5
59
132
WX892
NOMESCO Finland
Monitored bed care
4.9
16.2
54
112
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
16.1
173
831
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
15.9
85
270
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.5
15.9
57
128
ZX114
NOMESCO Finland
Intramuscular
18.2
15.7
24
13
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.0
15.6
96
334
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.1
15.4
61
151
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.3
15.2
47
90
ZXA10
NOMESCO Finland
Bilateral
2.6
15.0
118
481
183
Kela drug reimbursment
Lamotrigin and topiramate
15.8
14.9
24
15
RS222
NOMESCO Finland
NA
10.7
14.7
28
26
RL130
NOMESCO Finland
NA
12.2
14.6
26
21
R68.1
ICD-10 Finland
Nonspecific symptoms peculiar to infancy
55.5
14.5
17
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.5
14.4
43
79
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.1
14.4
35
49
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
14.4
14
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
78.3
14.3
16
*
R4130
NOMESCO Finland
Speech therapy
9.9
14.1
28
28
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
26.6
14.0
19
7
N03AX09
ATC
lamotrigine; oral
4.3
14.0
53
126
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
21.8
13.9
20
9
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
13.9
72
223
C03DA01
ATC
spironolactone; oral
6.7
13.9
35
52
ZXD05
NOMESCO Finland
Urgent procedure
2.1
13.8
173
883
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
13.4
135
625
G40.89
ICD-10 Finland
Other epilepsy
+∞
13.4
13
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
13.2
64
189
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
25.2
13.1
18
7
A11CC03
ATC
alfacalcidol; systemic
12.6
13.1
23
18
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
17.9
13.1
20
11
A28
ICPC
Limited function/disability NOS
4.9
13.0
43
89
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
10.3
12.9
25
24
ZY010
NOMESCO Finland
Hospital outpatient
2.7
12.9
90
341
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.1
12.9
50
122
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
12.7
181
972
H50.0
ICD-10 Finland
Convergent concomitant strabismus
6.6
12.6
32
48
ZX120
NOMESCO Finland
Intravenous
3.8
12.5
54
145
C03CA01
ATC
furosemide; systemic
5.4
12.5
37
68
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
12.5
79
280
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
12.5
72
242
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.7
12.3
31
46
ZXA00
NOMESCO Finland
Right side
2.6
12.3
92
362
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.7
12.3
28
36
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
12.3
136
657
RT190
NOMESCO Finland
NA
23.8
12.2
17
7
201
Kela drug reimbursment
Chronic cardiac insufficiency
8.6
12.2
26
30
127
Kela drug reimbursment
Transplant complication
12.9
12.2
21
16
ZX199
NOMESCO Finland
Other rote
36.6
12.0
15
*
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
6.4
12.0
31
48
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
11.9
61
188
TAB00
NOMESCO Finland
Lumbar puncture
5.6
11.9
34
60
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
20.8
11.8
17
8
RS220
NOMESCO Finland
NA
7.4
11.6
27
36
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.9
11.5
37
75
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
11.5
79
297
205
Kela drug reimbursment
Chronic hypertension
6.2
11.4
30
48
XX4AW
NOMESCO Finland
NA
10.9
11.3
21
19
XF404
NOMESCO Finland
Ambulatory ECG
3.7
11.3
49
133
RT274
NOMESCO Finland
NA
116.7
11.3
12
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.4
11.2
24
28
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
34.1
11.1
14
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.5
11.0
32
58
E34.30
ICD-10 Finland
Short stature NOS
8.7
11.0
23
26
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
9.4
11.0
22
23
V03AG01
ATC
sodium cellulose phosphate; systemic
16.6
11.0
17
10
TJD20
NOMESCO Finland
Change of gastrostomy tube
24.4
10.9
15
6
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.5
10.9
85
344
N05AH04
ATC
quetiapine; oral
2.2
10.8
126
617
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.9
10.8
24
30
R5140
NOMESCO Finland
Monitoring the use of the aid
6.3
10.8
28
44
B01AA03
ATC
warfarin; systemic
6.0
10.7
29
48
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
42.2
10.7
13
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
10.7
449
3391
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.5
10.6
50
145
E34.31
ICD-10 Finland
Short stature, prenatal disorder
11.6
10.6
19
16
JDB10
NOMESCO Finland
Percutaneous gastrostomy
27.3
10.5
14
5
SPAT1229
SPAT
Assessment of need for aid
6.4
10.5
27
42
P94.2
ICD-10 Finland
Congenital hypotonia
58.3
10.4
12
*
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
58.3
10.4
12
*
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
10.3
145
769
XF602
NOMESCO Finland
Bloodpressure monitoring
11.0
10.3
19
17
H03AA01
ATC
levothyroxine sodium; systemic
2.5
10.3
81
329
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.3
10.3
52
160
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
13.9
10.2
17
12
K03.66
ICD-10 Finland
Tooth plaque
2.2
10.2
105
489
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
10.1
51
157
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
10.3
10.0
19
18
C08CA01
ATC
amlodipine; oral
4.1
10.0
38
92
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
9.9
94
420
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
9.9
58
198
UDC00
NOMESCO Finland
Ear microscopy
2.6
9.8
72
281
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
14.2
9.8
16
11
P07.3
ICD-10 Finland
Other preterm infants
3.6
9.7
43
119
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
16.3
9.7
15
9
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.9
9.6
39
100
XF622
NOMESCO Finland
Measurement of minute volume of heart
25.3
9.6
13
5
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.7
9.6
32
68
C09AA02
ATC
enalapril; systemic
4.7
9.6
32
68
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
7.9
9.6
21
26
R1250
NOMESCO Finland
Evaluation of functional capability
7.9
9.6
21
26
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
7.9
9.6
21
26
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
9.5
41
111
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
9.5
146
799
A03FA02
ATC
cisapride; oral, rectal
4.0
9.5
37
92
E23.00
ICD-10 Finland
Panhypopituitarism
53.4
9.5
11
*
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
53.4
9.5
11
*
N03AX16
ATC
pregabalin; oral
3.3
9.3
46
139
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
14.6
9.3
15
10
R63.4
ICD-10 Finland
Abnormal weight loss
8.9
9.3
19
21
XKD00
NOMESCO Finland
Uroflowmetry
3.5
9.3
42
119
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
9.2
9
*
5AB14
NOMESCO Finland
NA
+∞
9.2
9
*
RT130
NOMESCO Finland
NA
17.1
9.2
14
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.8
9.1
20
25
C01AA05
ATC
digoxin; systemic
13.3
9.0
15
11
Z94.0
ICD-10 Finland
Kidney transplant status
13.3
9.0
15
11
H52.0
ICD-10 Finland
Hypermetropia
3.7
9.0
38
102
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
8.9
238
1555
N03AX11
ATC
topiramate; oral
6.5
8.9
22
33
KAC00
NOMESCO Finland
Nephrectomy
35.6
8.9
11
*
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
35.6
8.9
11
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
35.6
8.9
11
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
11.2
8.8
16
14
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
6.1
8.8
23
37
WX002
NOMESCO Finland
Sedation and analgesia
2.4
8.7
74
313
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.4
8.6
76
327
AA1AD
NOMESCO Finland
CT of head and brain
2.9
8.6
50
170
N99
ICPC
Neurological disease other
48.5
8.5
10
*
XF402
NOMESCO Finland
ECG with work load test
4.1
8.4
32
78
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
8.3
22
36
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
8.3
50
174
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
8.7
8.3
17
19
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
87.2
8.3
9
*
N03AG04
ATC
vigabatrin; oral
+∞
8.2
8
*
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
8.2
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
8.2
87
407
XG413
NOMESCO Finland
Spirometry with oscillometry
9.2
8.1
16
17
WX722
NOMESCO Finland
PEEP
6.1
8.1
21
34
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.1
8.0
43
139
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
8.0
48
167
G40.10
ICD-10 Finland
Simple partial seizures
14.1
8.0
13
9
B34.9
ICD-10 Finland
Viral infection, unspecified
2.8
8.0
50
177
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.3
7.9
28
64
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
7.9
40
124
J96.1
ICD-10 Finland
Chronic respiratory failure
32.3
7.9
10
*
WX730
NOMESCO Finland
Conventional respirator
16.7
7.9
12
7
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
11.4
7.9
14
12
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
21.4
7.9
11
5
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.9
7.8
31
79
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.7
7.8
25
52
E30.09
ICD-10 Finland
Delayed puberty NOS
7.0
7.7
18
25
R11
ICD-10 Finland
Nausea and vomiting
2.4
7.7
65
274
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
7.5
7.7
17
22
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
7.6
113
609
K59.0
ICD-10 Finland
Constipation
3.0
7.6
41
134
UGC02
NOMESCO Finland
Rigid bronchoscopy
9.1
7.6
15
16
BC00A
NOMESCO Finland
NA
43.5
7.6
9
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.6
7.5
32
87
H52.2
ICD-10 Finland
Astigmatism
3.6
7.5
32
87
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
7.5
36
108
301
Kela drug reimbursment
Growth hormone
7.2
7.5
17
23
A02BC01
ATC
omeprazole; systemic
2.1
7.4
84
405
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
5.8
7.4
20
34
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
24.2
7.4
10
*
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
24.2
7.4
10
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.8
7.4
16
20
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
7.3
23
47
ZXA05
NOMESCO Finland
Left side
2.2
7.3
70
315
JDB00
NOMESCO Finland
Gastrostomy
77.4
7.3
8
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
77.4
7.3
8
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
7.3
28
70
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.9
7.3
28
70
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.9
7.3
17
24
R62
ICD-10 Finland
Lack of expected normal physiological development
+∞
7.2
7
*
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
5.8
7.1
19
32
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
7.1
35
107
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.1
7.1
26
62
61
HP
Catheterization and pressure measurement of the left side of the heart
15.3
7.1
11
7
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.7
7.1
29
77
Q93.8
ICD-10 Finland
Other deletions from the autosomes
29.0
7.0
9
*
UKC02
NOMESCO Finland
Cystoscopy
3.3
7.0
33
98
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
19.4
7.0
10
5
137
Kela drug reimbursment
Uraemia requiring dialysis
19.4
7.0
10
5
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.8
7.0
28
73
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
11.7
6.9
12
10
RK110
NOMESCO Finland
NA
11.7
6.9
12
10
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.8
6.9
44
159
F80.0
ICD-10 Finland
Specific speech articulation disorder
4.7
6.9
22
46
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.9
103
555
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.7
6.9
44
160
31
HP
Congenital heart failure surgery
8.5
6.9
14
16
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
9.7
6.8
13
13
DFF20
NOMESCO Finland
Audiometry for children
9.7
6.8
13
13
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.9
6.8
26
65
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
6.1
6.7
17
27
N03AX12
ATC
gabapentin; oral
3.4
6.7
31
91
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
6.7
58
247
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.0
6.7
36
118
DFF00
NOMESCO Finland
Pure tone audiometry
3.2
6.7
33
102
G91.1
ICD-10 Finland
Obstructive hydrocephalus
38.6
6.6
8
*
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
38.6
6.6
8
*
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
10.6
6.6
12
11
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
10.6
6.6
12
11
RS224
NOMESCO Finland
NA
6.5
6.6
16
24
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
16.2
6.6
10
6
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
16.2
6.6
10
6
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.6
6.6
28
77
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.3
6.6
23
53
B05DA
ATC
Isotonic solutions
21.8
6.5
9
*
G04BE03
ATC
sildenafil; oral
21.8
6.5
9
*
P05.1
ICD-10 Finland
Small for gestational age
7.0
6.5
15
21
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.2
6.5
23
54
N06BA04
ATC
methylphenidate; oral
2.3
6.5
57
247
N05AH03
ATC
olanzapine; systemic
2.5
6.5
48
189
WW500
NOMESCO Finland
Blood transfusion
6.2
6.4
16
25
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.6
6.4
14
18
R03BA02
ATC
budesonide; inhalant
1.8
6.4
110
624
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
5.7
6.4
17
29
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.0
6.4
34
111
XW000
NOMESCO Finland
Bone marrow biopsy
5.3
6.4
18
33
R04.0
ICD-10 Finland
Epistaxis
3.2
6.4
31
95
A12AA04
ATC
calcium carbonate; oral
9.7
6.4
12
12
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.6
6.3
15
22
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
67.5
6.3
7
*
N03AX15
ATC
zonisamide; oral
13.8
6.2
10
7
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
6.2
34
113
N05AN01
ATC
lithium; oral
5.5
6.2
17
30
H02AB04
ATC
methylprednisolone; systemic
2.8
6.2
38
136
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
6.2
6
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
+∞
6.2
6
*
4AA09
NOMESCO Finland
NA
+∞
6.2
6
*
R51
NOMESCO Finland
Aids services
+∞
6.2
6
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
+∞
6.2
6
*
N06AX11
ATC
mirtazapine; oral
1.8
6.1
109
622
BF20A
NOMESCO Finland
NA
17.4
6.1
9
5
H47.2
ICD-10 Finland
Optic atrophy
17.4
6.1
9
5
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.8
6.1
24
62
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.0
6.1
12
13
R5599
NOMESCO Finland
Other rehabilitation service
3.5
6.1
26
72
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
25.8
6.1
8
*
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
25.8
6.1
8
*
L28
ICPC
Limited function/disability (L)
2.5
6.1
44
173
C07AB07
ATC
bisoprolol; oral
2.2
6.1
60
275
H50.1
ICD-10 Finland
Divergent concomitant strabismus
5.8
6.1
16
27
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.5
6.1
44
174
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
6.1
46
185
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
488
1958
3.27
72.43
19.6
6.8
mmol/l
1.2
1.2
1.08
470
1835
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
507
2096
3.23
71.25
17.4
6.2
mmol/l
1.2
1.2
0.83
475
1882
(3021447) Carbon dioxide [Partial pressure] in Venous blood
269
787
3.70
64.96
11.1
5.2
kpa
5.8
5.8
0.26
259
771
(3002032) Base excess in Venous blood by calculation
267
784
3.67
64.04
11.2
5.2
mmol/l
0.9
1.1
0.44
212
582
(3024354) Oxygen [Partial pressure] in Venous blood
257
740
3.72
63.40
10.9
5.1
kpa
5.1
5.2
0.03
248
727
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
243
716
3.58
57.40
11.1
4.7
mmol/l
23.6
23.5
0.19
235
690
(3003458) Phosphate [Moles/volume] in Serum or Plasma
263
845
3.31
53.93
15.0
5.9
mmol/l
1.3
1.3
0.16
256
807
(3000991) Gas panel - Venous blood
241
734
3.44
53.80
16.7
6.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
195
519
3.82
53.22
15.4
6.3
mmol/l
0.8
0.8
2.40
185
497
(3014111) Lactate [Moles/volume] in Serum or Plasma
143
346
4.03
44.17
17.1
10.9
mmol/l
1.5
1.3
0.60
132
317
(3022313) Gas panel - Capillary blood
216
697
3.16
43.11
16.2
5.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
210
689
3.09
40.55
16.8
5.9
kpa
9.5
9.6
0.32
203
670
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
226
776
2.98
40.29
16.7
5.8
mmol/l
0.9
1.0
0.18
178
554
(3009343) pH of Capillary blood
226
778
2.97
40.09
16.7
5.8
ph
7.4
7.4
—
6
18
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
226
779
2.97
39.99
16.8
5.8
kpa
5.1
5.0
0.42
221
750
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
209
710
2.97
37.77
16.7
5.7
mmol/l
24.0
24.1
0.26
209
705
(40758558) Short blood count panel - Blood
365
1678
2.40
35.70
9.3
5.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
327
1442
2.44
34.94
9.9
5.4
g/l
38.0
38.6
1.06
310
1358
(3013826) Glucose [Moles/volume] in Serum or Plasma
507
2719
2.26
34.17
10.9
4.5
mmol/l
5.9
6.2
2.57
474
2388
(3018418) pH of Serum or Plasma
236
913
2.63
32.97
5.3
3.0
ph
7.4
7.4
0.31
32
152
(3002582) Erythrocytes [#/volume] in Urine
333
1520
2.36
32.55
5.6
2.7
e6/l
12.3
66.1
2.04
258
1105
(36304419) Bacteria [Presence] in Urine
318
1441
2.35
31.43
5.6
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
124
343
3.45
31.20
10.5
5.0
ng/l
1562.1
804.1
0.64
113
256
(3030467) Casts [#/volume] in Urine by Automated count
311
1409
2.33
30.63
5.6
2.7
e6/l
0.2
0.2
0.08
237
1014
(3036481) Cortisol [Moles/volume] in Serum or Plasma
163
542
2.93
30.17
3.0
1.9
nmol/l
309.2
374.0
4.39
157
510
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
365
1787
2.22
29.71
9.3
4.3
umol/l
21.6
18.9
0.53
335
1611
(3035637) Corticotropin [Mass/volume] in Plasma
72
138
4.82
29.59
1.9
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
231
931
2.51
29.32
4.6
2.2
mosm/kgh2o
546.8
602.5
2.55
201
784
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
551
3184
2.12
29.12
7.5
4.2
u/l
125.1
100.2
7.60
522
2954
(3000850) Epithelial cells [#/volume] in Urine
235
967
2.46
28.45
4.7
2.2
e6/l
8.2
7.7
0.13
207
830
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
408
2116
2.14
28.45
4.7
2.4
nmol/l
69.6
66.2
1.92
390
1990
(3033658) Prothrombin time (PT) actual/Normal
269
1181
2.34
28.15
9.9
4.7
%
84.4
87.8
1.36
264
1165
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
210
827
2.53
27.86
4.1
2.6
e6/l
3.7
3.3
0.15
125
453
(3019550) Sodium [Moles/volume] in Serum or Plasma
804
5443
2.42
27.83
19.3
6.1
mmol/l
139.4
139.4
0.04
790
5191
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
211
836
2.52
27.62
4.1
2.5
e6/l
0.7
1.0
0.77
124
459
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
341
1670
2.18
27.29
6.0
2.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
801
5438
2.39
27.08
19.4
6.1
mmol/l
3.9
3.9
3.98
781
5160
(3023368) Bacteria identified in Blood by Culture
189
720
2.58
26.78
4.7
2.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
158
552
2.77
26.53
4.4
2.0
g/l
2.5
2.6
1.42
151
511
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
150
512
2.82
26.30
8.5
3.7
umol/l
7.0
6.6
0.14
129
419
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
147
500
2.83
25.92
4.8
2.1
%
20.4
22.5
1.09
139
460
(3015377) Calcium [Moles/volume] in Serum or Plasma
255
1132
2.29
25.72
3.3
2.1
mmol/l
2.4
2.4
0.29
239
1014
(3036489) Thrombin time
97
259
3.50
25.64
5.8
4.8
s
22.9
23.1
0.12
92
240
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
57
103
5.05
25.03
13.4
4.6
iu/ml
239.1
771.7
—
11
6
(3011412) CD3 cells [#/volume] in Blood
48
74
5.88
24.92
4.4
2.0
e9/l
1.5
1.8
0.41
36
44
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
47
71
6.00
24.89
4.5
2.0
%
8.0
9.0
0.43
42
60
(3018095) Leukocytes [#/volume] in Urine
372
1938
2.06
24.87
6.7
3.2
e6/l
41.8
54.3
0.24
266
1191
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
60
6.47
24.56
2.3
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
165
619
2.58
23.96
4.4
2.0
umol/l
13.1
14.3
1.38
159
589
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
87
5.32
23.85
2.3
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
46
72
5.78
23.52
4.2
2.0
e9/l
0.2
0.2
1.05
38
51
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
72
5.78
23.52
4.2
2.0
e6/l
624.3
595.8
0.12
38
51
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
66
6.02
23.46
4.7
2.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
68
156
4.00
22.28
7.7
5.0
ng/l
166.5
185.9
0.12
60
133
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
50
91
4.98
21.77
2.4
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
145
537
2.58
21.50
6.6
4.1
%
1.4
1.4
0.08
140
501
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
22
10.12
20.49
4.8
4.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
40
63
5.71
20.32
5.0
2.2
e6/l
319.4
434.9
0.60
32
37
(3007853) Bacteria identified in Skin by Aerobe culture
163
656
2.39
20.19
2.2
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
499
3029
1.86
20.08
10.5
5.7
%
0.6
0.6
1.49
477
2872
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
15
12.43
19.54
9.0
6.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
569
3637
1.83
18.99
13.2
6.4
e9/l
3.8
3.6
0.79
502
3030
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
37
58
5.73
18.88
2.0
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
523
3272
1.82
18.57
10.4
5.6
e9/l
0.0
0.0
0.07
457
2732
(3006504) Eosinophils/100 leukocytes in Blood
506
3136
1.81
18.51
10.5
5.6
%
3.0
3.2
0.52
482
2964
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
53
5.92
18.48
2.3
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
33
47
6.29
18.48
2.6
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
522
3267
1.81
18.48
10.4
5.6
e9/l
0.6
0.5
5.44
455
2727
(44790049)
40
70
5.14
18.19
2.1
1.9
—
—
—
0
0
(44790047)
40
70
5.14
18.19
2.1
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
333
2.79
18.16
2.3
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
54
122
4.02
18.06
3.1
2.4
—
—
—
0
0
(44790048)
40
71
5.07
17.91
2.1
1.9
—
—
—
0
0
(44806118)
40
71
5.07
17.91
2.1
1.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
505
3165
1.78
17.43
10.8
5.7
%
8.4
8.0
2.30
483
3002
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
99
336
2.74
17.33
2.4
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
531
3382
1.78
17.29
12.1
5.8
e9/l
0.2
0.2
0.54
478
2878
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
178
796
2.15
16.99
4.3
2.7
mg/l
2.6
1.6
0.75
138
517
(3044640) Blood type and Crossmatch panel - Blood
280
1474
1.91
16.97
3.8
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
398
2346
1.79
16.72
11.5
5.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1189
1.95
16.21
3.6
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
535
3462
1.74
16.00
10.4
5.5
e9/l
2.4
2.3
0.83
482
2981
(3002030) Lymphocytes/100 leukocytes in Blood
525
3385
1.73
15.85
10.3
5.4
%
33.8
34.9
1.25
502
3219
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
127
508
2.35
15.78
2.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
829
6124
2.01
15.78
11.1
5.7
u/l
29.6
26.0
0.84
812
5853
(3018010) Neutrophils/100 leukocytes in Blood
516
3325
1.72
15.48
10.2
5.3
%
50.6
50.6
0.01
495
3168
(3003396) Base excess in Arterial blood by calculation
74
228
2.97
15.44
22.6
10.7
mmol/l
-0.8
-0.2
0.47
55
180
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
276
1485
1.85
15.42
5.2
3.1
u/l
32.6
31.9
0.17
269
1417
(3049233) Organic acids panel - Urine
21
22
8.47
15.19
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
206
1018
1.96
14.84
5.8
3.1
inr
1.1
1.1
0.79
44
340
(3009508) Creatinine [Moles/volume] in Urine
245
1284
1.87
14.79
5.0
3.9
mmol/l
7.8
9.4
3.61
233
1176
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
19
18
9.35
14.76
2.1
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
54
141
3.47
14.73
12.3
9.7
%
1.1
1.3
0.56
54
141
(3021589) Normoblasts [#/volume] in Blood
496
3190
1.70
14.72
11.7
6.5
e9/l
0.0
0.0
0.49
392
2469
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
118
474
2.32
14.49
5.1
2.7
ng/l
828.0
1381.8
0.81
73
222
(3009214) Lutropin [Units/volume] in Serum or Plasma
116
464
2.33
14.38
2.5
1.8
u/l
5.4
6.6
1.07
82
334
(3044290) Cell count panel - Cerebral spinal fluid
41
90
4.09
14.25
2.6
2.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
21
9
20.71
14.05
5.5
4.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
21
9
20.71
14.05
6.1
5.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
18
17
9.37
14.00
2.2
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
62
4.76
13.88
28.3
26.1
u/ml
0.3
0.3
0.27
20
31
(3037121) Protein [Mass/volume] in Urine
69
220
2.86
13.55
7.2
6.4
g/l
0.3
0.4
0.60
53
147
(3023520) Reticulocytes [#/volume] in Blood
96
363
2.44
13.47
4.7
3.1
e9/l
67.7
64.1
0.34
74
217
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46
115
3.60
13.39
1.6
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46
115
3.60
13.39
1.6
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
79
4.19
13.34
2.3
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
53
146
3.28
13.32
3.7
2.9
mu/l
15.5
29.5
1.60
53
133
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
9
19.71
13.21
7.6
6.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
71
236
2.74
12.91
1.4
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
102
408
2.31
12.62
2.6
1.9
iu/l
6.6
7.7
0.44
69
294
(3042733) HLA Ab [Presence] in Serum
19
23
7.31
12.25
3.6
4.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
25
41
5.42
12.19
4.6
4.5
mmol/l
29.2
40.7
1.33
25
41
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
23
35
5.83
12.09
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
45
5.14
11.98
2.1
1.8
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
26
45
5.14
11.98
3.2
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
82
3.93
11.94
2.2
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
32
67
4.26
11.83
4.2
4.3
umol/l
22.6
24.3
0.70
32
67
(3042936) Bacteria identified in Isolate by Culture
112
479
2.17
11.79
2.5
1.6
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
33
73
4.04
11.38
5.7
7.4
g/mol
129.7
175.7
0.13
26
67
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
35
5.57
11.07
1.8
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
657
4743
1.59
10.69
4.1
3.3
pmol/l
14.4
14.4
0.15
615
4215
(3021960) Folate [Moles/volume] in Serum or Plasma
140
675
1.94
10.63
1.5
1.3
nmol/l
18.7
18.8
0.04
128
594
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
845
6514
1.81
10.58
15.9
6.4
mg/l
22.1
22.1
0.00
639
4344
(3002385) Erythrocyte distribution width [Ratio]
816
6232
1.74
10.49
21.2
8.7
%
13.4
13.0
8.86
803
6081
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
100
3.40
10.29
2.7
2.2
e6/l
43.5
29.4
0.16
28
69
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
38
100
3.40
10.29
2.7
2.2
e6/l
243.5
43967.7
0.52
29
70
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
48
4.62
10.27
1.7
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
24
45
4.73
10.14
4.4
2.4
—
—
—
0
0
(4035726)
56
187
2.70
10.12
2.4
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
39
106
3.29
10.05
7.9
4.6
mmol/l
23.3
23.3
0.02
39
93
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
130
3.04
9.91
33.7
13.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
29
65
3.97
9.85
3.1
2.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
57
195
2.64
9.84
3.2
1.5
u/ml
70.0
86.4
—
7
19
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
245
1428
1.65
9.73
2.8
2.8
mg/l
2.7
2.5
0.83
225
1252
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
50
161
2.79
9.68
31.2
13.9
%
0.7
0.7
0.00
50
161
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
57
197
2.61
9.65
3.2
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
231
1332
1.66
9.54
3.9
2.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
168
2.73
9.47
1.8
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
88
3.45
9.45
1.3
1.3
ug/g
339.3
396.7
0.68
21
45
(40761511) CBC panel - Blood by Automated count
864
6761
1.80
9.44
12.1
5.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
730
5473
1.59
9.39
4.5
3.6
mu/l
2.0
1.9
2.18
696
5119
(3031040) Bacteria [#/volume] in Urine by Automated count
523
3649
1.52
9.35
5.5
3.0
e6/l
8200.8
369.2
0.47
12
26
(3051611) Lipemic interference index of Serum or Plasma
26
56
4.12
9.30
4.4
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
72
284
2.30
9.21
2.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
109
3.11
9.00
3.3
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1055
1.70
9.00
2.3
2.2
u/l
53.6
57.3
0.78
176
963
(3037467) Urinalysis macro (dipstick) panel - Urine
541
3822
1.50
8.95
5.8
3.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
35
97
3.22
8.77
4.9
6.0
ug/l
2.7
1.7
1.46
35
97
(3003338) MCHC [Mass/volume]
847
6626
1.71
8.74
20.7
8.4
g/l
334.5
335.0
0.86
839
6535
(3024928) Oxygen saturation in Venous blood
33
89
3.30
8.63
16.7
11.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
95
431
2.01
8.55
2.6
1.8
nmol/l
8.0
10.4
1.68
85
373
(3007164) IgA [Mass/volume] in Serum or Plasma
345
2246
1.51
8.30
1.9
1.5
g/l
1.6
1.7
0.77
188
1152
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
16
7.15
8.23
2.6
1.8
umol/l
20.1
13.7
0.83
13
16
(40768446) Kidney Pathology biopsy report
19
35
4.80
8.20
3.4
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
354
2328
1.50
8.06
4.8
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
67
275
2.20
7.82
2.6
1.4
u/ml
195.4
178.4
0.19
38
130
(3018738) Hemoglobin F/Hemoglobin.total in Blood
22
48
4.06
7.76
4.3
3.4
%
5.0
4.4
—
10
14
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
42
4.21
7.41
1.8
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
63
3.52
7.26
5.0
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
223
1355
1.56
7.22
2.9
1.9
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
11
13
7.44
7.17
1.5
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
205
2.32
7.13
2.6
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
11
7.98
6.87
1.2
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
484
3474
1.41
6.54
4.1
2.8
mmol/mol
35.4
36.2
0.96
464
3286
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
416
1.87
6.45
1.7
1.8
mmol/l
2.4
2.4
0.09
71
347
(3024932) HLA-DR beta [Type]
13
21
5.45
6.43
1.2
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
13
21
5.45
6.43
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
23
60
3.39
6.37
2.9
2.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
166
2.37
6.28
2.7
2.4
ml/min/173m2
91.4
97.9
—
10
50
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
25
4.93
6.25
1.1
1.1
—
—
—
0
0
(3015736) pH of Urine
317
2126
1.44
6.20
3.9
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
22
57
3.41
6.16
21.8
16.4
%
11.5
12.1
0.48
22
57
(3020891) Body temperature
27
80
2.99
6.13
6.9
7.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
19
5.55
6.05
1.8
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
16
6.04
6.00
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
16
6.04
6.00
1.4
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
16
6.04
6.00
1.5
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
16
6.04
6.00
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
157
917
1.58
5.97
1.8
1.6
mmol/l
1.3
1.2
0.83
149
832
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
202
1249
1.51
5.95
1.9
1.4
pmol/l
95.5
98.2
0.37
110
666
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
30
4.40
5.90
1.7
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
10
7
12.54
5.89
1.7
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
93
476
1.77
5.83
1.8
1.5
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
9
5
15.79
5.80
1.0
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
65
298
1.96
5.73
4.4
3.9
%
0.8
0.4
0.46
24
45
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
39
3.84
5.65
1.4
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
8
10.98
5.58
2.3
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
516
3807
1.37
5.58
5.6
3.2
mm/h
7.6
6.9
1.00
493
3482
(36660697) Celiac disease serology panel - Serum
168
1012
1.53
5.56
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
32
4.13
5.47
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
344
2384
1.39
5.44
2.5
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
53
3.33
5.44
2.0
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
947
7835
1.89
5.40
22.6
9.5
fl
86.3
87.0
4.63
938
7682
(3035941) MCH [Entitic mass]
947
7836
1.89
5.38
22.6
9.5
pg
28.9
29.2
5.13
938
7685
(3007461) Platelets [#/volume] in Blood
946
7826
1.88
5.37
22.7
9.6
e9/l
269.7
267.0
0.57
920
7440
(3026361) Erythrocytes [#/volume] in Blood
947
7838
1.88
5.34
22.6
9.6
e12/l
4.6
4.7
0.38
917
7432
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
45
3.53
5.33
3.5
2.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
18
45
3.53
5.33
15.9
13.9
nmol/l
724.0
724.5
0.00
18
45
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
18
45
3.53
5.33
20.9
23.6
nmol/l
1091.6
1243.2
0.36
18
45
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
45
3.53
5.33
3.5
2.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
67
320
1.88
5.26
5.3
4.1
%
1.0
0.7
0.20
27
70
(3000963) Hemoglobin [Mass/volume] in Blood
947
7843
1.87
5.25
23.5
9.7
g/l
133.3
135.6
5.25
939
7694
(3010813) Leukocytes [#/volume] in Blood
947
7846
1.87
5.19
22.7
9.6
e9/l
7.0
6.8
2.23
919
7448
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
96
514
1.69
5.15
1.5
1.4
pmol/l
490.2
25618394.7
0.78
85
445
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
28
94
2.64
5.12
1.6
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
19
5.08
5.08
4.1
2.1
u/ml
1284.0
487.6
1.32
11
19
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
15
35
3.77
4.89
1.9
1.6
nmol/l
19.7
16.7
—
6
13
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
97
2.56
4.83
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
110
622
1.61
4.78
2.1
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
24
4.39
4.73
4.4
3.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
24
4.39
4.73
4.4
3.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
13
28
4.08
4.69
4.7
3.8
ug/l
20.8
22.4
0.19
13
28
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
6
11.69
4.68
4.1
2.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
107
607
1.60
4.60
1.6
1.3
u/ml
206.9
459.3
1.56
99
569
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
30
111
2.39
4.53
2.8
2.2
g/l
1.0
1.1
0.18
24
91
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
73
378
1.73
4.44
2.4
2.1
u/l
25.3
30.7
1.97
65
310
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
18
4.88
4.42
3.5
5.7
ug/l
190.2
235.2
—
10
18
(3021440) Promyelocytes/100 leukocytes in Blood
63
313
1.80
4.40
5.4
4.1
%
0.1
0.1
0.13
27
65
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
129
772
1.52
4.39
2.8
1.7
ng/l
55.1
62.7
0.07
55
249
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
102
2.43
4.38
3.3
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
47
3.19
4.36
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
176
2031
0.70
4.29
1.8
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
25
483
0.44
4.24
1.4
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
17
48
3.12
4.22
2.6
2.5
mmol/l
1.5
1.9
0.72
17
48
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
8
8.77
4.13
1.6
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
8
8.77
4.13
1.6
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
8
8.77
4.13
1.6
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
8
8.77
4.13
1.6
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
462
3453
1.30
4.10
5.0
2.7
u/l
30.2
24.7
2.57
448
3283
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
26
95
2.42
4.06
1.7
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
64
2.76
4.03
8.2
3.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
46
213
1.92
4.01
1.0
1.0
mu/l
9.5
8.2
0.58
41
182
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
45
3.13
4.00
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
49
232
1.88
4.00
5.4
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
12
6.58
3.93
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
533
4075
1.29
3.93
2.9
2.1
mmol/l
5.4
5.4
0.13
498
3740
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
29
512
0.48
3.87
1.5
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
29
114
2.25
3.87
5.7
3.8
u/ml
41.4
5.6
0.72
29
99
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
29
3.63
3.74
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
10
21
4.18
3.72
2.8
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
110
660
1.51
3.71
1.6
1.5
titre
232.5
523.5
3.09
16
113
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
146
2.06
3.67
1.4
1.3
—
—
—
0
0
(4062490)
21
73
2.54
3.64
1.7
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
48
2.93
3.62
11.3
4.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
38
171
1.97
3.62
1.0
1.0
mmol/l
-2.2
-1.9
—
5
36
(3006598) pH of Arterial cord blood
38
171
1.97
3.62
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
349
2545
1.30
3.61
1.6
1.7
u/ml
3.2
3.3
0.02
61
523
(3025159) Blasts/100 leukocytes in Blood
59
306
1.72
3.61
5.5
4.2
%
0.0
0.0
0.00
26
55
(3035350) Ketones [Presence] in Urine by Test strip
366
2687
1.29
3.60
4.2
2.6
estimate
0.0
0.0
0.00
55
491
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
30
3.51
3.58
1.7
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
30
3.51
3.58
1.7
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
30
3.51
3.58
1.7
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
14
5.64
3.57
2.0
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
429
3219
1.28
3.53
4.0
2.6
ug/l
53.2
46.6
0.66
414
3025
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
44
3.00
3.53
1.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
10
22
3.99
3.52
10.0
7.2
mmol/l
1.2
1.2
—
10
17
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
5
10.50
3.46
1.5
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
5
10.50
3.46
1.5
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
852
7000
1.39
3.44
21.2
8.0
%
39.1
40.2
6.06
779
6107
(40767503) Oxygen content in Capillary blood by calculation
17
55
2.72
3.39
3.2
2.6
%
16.8
18.6
2.19
11
32
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
87
1093
0.66
3.30
1.5
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
364
2697
1.27
3.26
6.1
3.7
estimate
0.0
0.0
0.00
64
520
(3009261) Glucose [Presence] in Urine by Test strip
365
2712
1.27
3.17
4.2
2.6
estimate
0.0
0.0
0.00
62
503
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
22
84
2.31
3.17
2.0
2.1
mmol/l
2.8
2.3
0.29
14
69
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
34
531
0.54
3.14
1.6
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
525
4076
1.25
3.12
8.9
4.6
ml/min/173m2
111.9
110.0
1.17
373
2776
(3013512) EKG study
105
649
1.46
3.08
2.7
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
48
2.75
3.06
2.1
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
29
3.33
3.05
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
29
3.33
3.05
2.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
32
145
1.95
3.03
8.5
5.5
inr
1.9
1.1
—
6
27
(3012516) Albumin [Mass/volume] in Urine
91
549
1.49
3.02
4.1
4.1
mg/l
183.5
115.9
0.58
73
443
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
7
7.50
2.97
1.5
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
210
1.77
2.96
2.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
258
2687
0.78
2.95
2.6
2.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
67
381
1.57
2.92
1.6
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
63
354
1.59
2.89
2.4
3.3
pmol/l
4.9
5.1
0.53
58
324
(3048689) Calprotectin [Mass/mass] in Stool
179
1226
1.33
2.86
2.8
3.2
ug/g
143.4
112.4
0.26
139
957
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
11
5.57
2.86
1.6
2.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
20
77
2.29
2.85
2.8
3.2
ug/l
2.2
1.8
0.49
12
47
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
124
1.99
2.84
2.8
2.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
194
1.78
2.80
1.3
1.1
—
—
—
0
0
(4198724)
22
89
2.18
2.80
1.8
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
31
3.11
2.77
1.2
1.2
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
5
5
8.74
2.73
2.6
2.2
mmol/l
77.2
107.6
—
5
5
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
12
5.11
2.70
1.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
241
2505
0.79
2.67
2.4
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
195
1366
1.30
2.65
1.7
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
32
3.01
2.64
1.2
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
17
63
2.37
2.64
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
47
2.62
2.64
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
42
2.72
2.63
1.9
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
21
3.75
2.61
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
95
597
1.43
2.58
1.1
1.2
—
61.2
—
0
6
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
81
2.17
2.56
1.3
1.3
u/ml
4.1
3.5
0.11
11
36
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
13
4.71
2.55
2.4
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
13
4.71
2.55
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
87
2.12
2.54
5.0
3.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
48
2.56
2.54
1.7
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
59
2.38
2.52
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
89
558
1.43
2.46
5.0
4.7
mg/mmol
20.9
10.7
0.78
72
446
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
14
4.38
2.42
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
14
4.38
2.42
1.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
34
2.84
2.40
2.9
2.4
%
88.8
92.0
0.32
11
34
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
117
774
1.36
2.37
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
84
2.09
2.36
1.3
1.2
u/ml
1.8
3.0
0.65
11
30
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
295
1.56
2.33
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
33
166
1.76
2.33
1.9
1.6
g/l
0.2
0.2
0.93
33
159
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
40
2.63
2.30
2.2
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
27
128
1.86
2.30
1.9
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
15
4.08
2.29
2.4
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
11
4.77
2.27
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
533
4235
1.20
2.22
3.5
2.3
mmol/l
4.4
4.4
0.77
522
4009
(3020874) Milk IgE Ab [Units/volume] in Serum
35
182
1.70
2.21
1.1
1.5
u/ml
1.8
4.1
1.03
24
132
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
33
169
1.72
2.20
1.9
1.6
g/l
1.0
1.1
1.20
33
160
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
31
2.83
2.18
2.4
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
87
2.02
2.17
2.9
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
58
2.27
2.16
11.4
6.0
mmol/l
1.3
2.1
—
8
32
(3027315) Oxygen [Partial pressure] in Blood
15
58
2.27
2.16
11.5
6.0
kpa
9.8
9.5
0.18
15
58
(3013290) Carbon dioxide [Partial pressure] in Blood
15
58
2.27
2.16
11.4
6.0
kpa
5.0
4.9
0.13
15
58
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
12
4.37
2.13
2.8
2.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
12
4.37
2.13
3.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
93
1067
0.73
2.13
1.4
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
70
2.13
2.12
1.0
1.0
g/l
1.5
1.4
0.29
17
60
(3019309) Folate [Moles/volume] in Red Blood Cells
60
361
1.48
2.08
1.5
1.5
nmol/l
1054.0
1020.3
0.12
45
273
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
17
3.60
2.06
1.9
2.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
107
715
1.34
2.05
1.3
1.3
—
422.4
—
0
36
(3003740) Influenza virus B Ag [Presence] in Specimen
37
200
1.63
2.05
1.5
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
200
1.63
2.05
1.5
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
22
3.18
2.04
2.4
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
54
2.27
2.03
1.3
1.3
—
—
—
0
0
(4027681)
11
38
2.54
1.99
1.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
9
4.85
1.98
1.2
1.7
mu/l
1319.7
70.1
—
5
9
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
18
3.40
1.96
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
18
3.40
1.96
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
18
3.40
1.96
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
18
3.40
1.96
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
242
1802
1.22
1.94
1.8
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
14
3.75
1.89
4.0
1.6
e9/l
0.2
0.2
—
6
14
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
499
3980
1.18
1.87
3.3
2.2
mmol/l
1.2
1.1
2.43
483
3773
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
68
2.07
1.87
1.4
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
81
527
1.37
1.86
1.7
1.7
mu/l
444.8
312.8
2.13
75
472
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
30
2.63
1.81
1.7
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
144
1521
0.79
1.78
2.0
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
132
1408
0.79
1.77
1.9
2.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
20
3.06
1.77
1.4
1.9
nmol/l
3.8
1.4
—
7
20
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
368
0.60
1.77
1.5
1.8
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
32
174
1.62
1.76
1.3
1.4
u/ml
2.0
11.2
0.94
21
117
(4268621)
14
58
2.12
1.75
2.6
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
63
398
1.40
1.73
3.2
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
11
3.97
1.72
1.0
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
11
3.97
1.72
1.0
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
11
3.97
1.72
4.2
1.5
%
11.4
8.8
—
5
11
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
11
3.97
1.72
1.0
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
11
3.97
1.72
4.2
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
48
591
0.69
1.71
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
47
2.24
1.70
1.3
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
122
1.73
1.69
1.2
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
16
3.28
1.68
1.3
2.1
mmol/l
4.1
3.8
—
6
16
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
16
3.28
1.68
1.0
1.1
—
—
—
0
0
(4306422)
15
65
2.02
1.68
1.1
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
5
12
3.64
1.61
34.4
14.0
umol/l
0.3
0.5
—
5
12
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
22
2.78
1.60
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
21
105
1.76
1.58
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
187
1.55
1.56
1.4
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
27
147
1.62
1.51
1.3
1.5
umol/l
5.2
5.0
0.06
27
137
(3045788) Cell count panel - Pleural fluid
5
13
3.36
1.50
1.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
142
1.61
1.44
2.5
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
51
2.06
1.43
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
19
2.76
1.42
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
28
157
1.57
1.41
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
348
1.37
1.37
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
951
1.23
1.36
1.7
1.4
%
1.3
1.3
0.68
116
866
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
21
2.50
1.28
1.0
1.0
g/l
0.0
0.0
—
6
21
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
21
2.50
1.28
1.0
1.0
g/l
0.0
0.0
—
6
21
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
300
1.38
1.27
2.7
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
86
600
1.27
1.27
1.3
1.2
iu/ml
66.5
166.4
2.46
19
184
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
39
468
0.71
1.25
1.2
1.3
miu/ml
200.8
260.3
0.36
15
235
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
16
2.73
1.24
1.4
2.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
16
2.73
1.24
1.4
2.1
mmol/l
105.2
105.8
—
5
16
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
16
2.73
1.24
1.2
2.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
18
94
1.68
1.20
1.8
2.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
516
4216
1.13
1.20
3.5
2.3
mmol/l
2.7
2.7
0.07
503
3951
(3019150) Specific gravity of Urine by Refractometry
173
1307
1.18
1.20
3.7
2.5
kg/l
1.0
1.0
0.09
35
227
(3041806) Other cells [#/volume] in Blood by Manual count
9
150
0.52
1.20
2.2
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
157
1.51
1.19
1.9
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
52
342
1.34
1.19
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
143
1.54
1.18
1.3
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
49
1.96
1.18
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
321
1.35
1.15
3.6
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
81
569
1.26
1.15
2.5
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
510
4172
1.13
1.15
3.4
2.3
mmol/l
1.4
1.4
2.26
495
3937
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
82
1.71
1.15
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
26
2.35
1.12
1.3
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
35
2.00
1.10
1.3
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
447
0.73
1.10
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
90
1.66
1.10
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
28
2.18
1.07
1.3
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
39
2.02
1.05
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
88
632
1.23
1.05
1.3
1.2
iu/ml
11.7
15.5
0.68
22
150
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
29
2.11
1.04
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
40
1.97
1.04
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
40
1.97
1.04
2.9
2.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
85
1.65
1.03
1.3
1.2
—
1.6
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
60
413
1.28
1.02
1.5
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
52
1.85
1.02
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
439
0.74
1.00
2.0
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
79
1.66
1.00
1.3
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
42
1.87
1.00
1.0
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
9
42
1.87
1.00
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
59
1.78
1.00
1.6
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
815
7278
0.87
0.98
4.1
3.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
43
1.83
0.97
1.7
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
72
762
0.81
0.96
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
693
0.80
0.93
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
170
1663
0.87
0.93
2.2
2.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
48
1.82
0.90
1.4
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
251
1.33
0.89
5.2
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
82
1.60
0.88
1.5
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
46
313
1.29
0.88
2.1
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
37
1.89
0.88
1.8
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
26
2.01
0.87
1.7
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
26
2.01
0.87
1.0
1.0
g/l
0.0
0.0
—
6
26
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
26
2.01
0.87
1.0
1.0
g/l
0.0
0.0
—
6
26
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
46
314
1.29
0.86
1.3
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
38
1.84
0.86
1.8
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
38
1.84
0.86
1.3
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
49
1.78
0.85
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
19
112
1.49
0.83
1.0
1.4
u/l
37.9
40.2
0.22
19
106
(46235355) HIV 1 and 2 tests - Meaningful Use set
301
2822
0.90
0.83
2.2
2.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
156
1.41
0.83
1.0
1.1
u/ml
2.1
8.7
—
8
53
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
24
287
0.72
0.82
1.5
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
26
164
1.39
0.81
1.2
1.1
iu/ml
5.0
4.7
—
7
27
(3014051) Protein [Presence] in Urine by Test strip
9
130
0.60
0.80
1.4
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
24
0.00
0.78
0.0
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
107
1.47
0.77
8.0
3.5
%
49.9
52.1
0.33
18
107
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
20
2.18
0.76
3.0
3.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
47
1.67
0.74
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
229
1.30
0.73
1.1
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
54
387
1.23
0.71
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
220
2076
0.90
0.68
1.8
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
126
1.39
0.65
2.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
78
586
1.17
0.64
1.3
1.2
u/ml
11.2
10.1
0.04
29
200
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
44
1.59
0.61
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
87
664
1.15
0.59
3.0
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
288
2357
1.09
0.58
1.7
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
47
1.49
0.57
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
708
1.14
0.57
1.3
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
75
0.58
0.57
1.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
153
1.32
0.56
1.3
1.3
u/ml
7.1
26.0
0.62
18
123
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
32
1.64
0.56
1.8
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
123
1.35
0.55
1.4
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
15
93
1.41
0.55
1.2
1.3
u/ml
3.3
5.7
0.65
15
84
(40760892) CBC W Ordered Manual Differential panel - Blood
162
1294
1.11
0.55
7.7
3.7
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
9
52
1.51
0.54
1.2
2.1
nmol/l
2.2
2.2
—
9
47
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
52
1.51
0.54
1.3
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
52
1.51
0.54
1.7
1.7
umol/l
12.3
10.1
—
9
52
(3028300) Cannabinoids [Presence] in Urine
108
1044
0.89
0.53
2.5
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
9
54
1.45
0.53
3.7
3.0
u/ml
6.3
87.0
—
9
49
(3027008) Opiates [Presence] in Urine
108
1042
0.89
0.52
2.3
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
137
0.70
0.51
1.1
1.6
—
—
—
0
0
(3000492) Spirometry study
63
477
1.16
0.50
1.7
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
52
388
1.18
0.49
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
39
1.57
0.49
1.0
1.1
nmol/l
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
14
88
1.39
0.48
1.0
1.0
g/l
167.6
164.4
0.18
14
88
(3029937) Albumin [Presence] in Urine by Test strip
174
1405
1.09
0.48
4.4
2.6
estimate
0.0
0.0
0.50
63
496
(3029396) Erythrocyte agglutination [Presence] in Blood
7
41
1.49
0.47
3.3
3.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
52
390
1.17
0.47
1.6
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
74
0.59
0.46
1.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
108
1031
0.90
0.45
2.3
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
149
1200
1.10
0.45
1.6
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
215
1.22
0.44
1.6
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
27
1.62
0.43
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
106
1.32
0.42
5.6
3.5
e9/l
2.9
3.3
0.33
16
106
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
11
68
1.41
0.42
2.6
8.7
mg/l
7.3
10.5
—
6
57
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
28
1.56
0.42
1.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
13
0.00
0.41
0.0
1.4
—
—
—
0
0
(4133840)
0
13
0.00
0.41
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
50
498
0.87
0.41
1.1
1.2
u/ml
2.7
0.9
0.59
34
356
(3004616) Nuclear Ab [Presence] in Serum
5
29
1.50
0.41
1.2
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
55
542
0.88
0.39
1.3
1.2
u/ml
3.1
2.8
0.06
39
354
(3001019) Free T4 and TSH panel - Serum or Plasma
29
301
0.83
0.39
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
108
1022
0.91
0.39
2.3
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
40
300
1.17
0.38
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
59
576
0.88
0.37
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
52
399
1.14
0.37
1.6
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
72
694
0.90
0.37
1.4
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
52
510
0.88
0.36
1.1
1.2
u/ml
7.9
6.6
0.20
38
388
(3010726) Horse dander IgE Ab [Units/volume] in Serum
50
491
0.88
0.35
1.1
1.2
u/ml
7.1
4.1
0.43
20
173
(40761536) Microorganisms panel - Urine sediment
49
481
0.88
0.34
5.2
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
102
960
0.92
0.34
2.3
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
84
0.72
0.31
6.1
1.4
%
12.9
12.9
—
7
84
(3035933) Granulocytes/100 leukocytes in Blood
14
96
1.27
0.31
1.1
1.3
—
—
—
0
0
(4010399)
31
309
0.87
0.28
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
54
1.29
0.28
5.5
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
65
1.21
0.25
1.3
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
206
1.14
0.23
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
24
239
0.87
0.23
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
35
1.24
0.22
2.8
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.21
0.0
1.9
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
91
0.76
0.21
1.4
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
23
175
1.15
0.21
2.8
2.6
ug/l
0.8
1.3
2.56
23
159
(4038314)
0
12
0.00
0.20
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
41
1.28
0.20
1.5
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
209
0.87
0.20
1.4
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
42
1.25
0.20
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
42
1.25
0.20
1.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
43
1.22
0.20
1.5
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
43
1.22
0.20
1.5
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
44
1.19
0.19
1.5
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
44
1.19
0.19
1.5
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
42
337
1.09
0.17
1.7
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
5
61
0.71
0.17
1.0
1.0
—
7.1
—
0
7
(3025130) Human papilloma virus identified in Specimen
11
80
1.20
0.16
1.9
1.9
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
70
1.12
0.15
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
130
1.14
0.15
1.4
1.1
—
—
—
0
0
(1002224) Polysomnography panel
15
114
1.15
0.14
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
329
0.92
0.14
2.6
1.9
%
31.3
33.3
0.46
27
247
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
198
1.10
0.13
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
157
0.89
0.13
1.4
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
35
283
1.08
0.13
1.0
1.1
u/ml
9.0
9.5
0.04
21
177
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
232
1977
1.03
0.12
4.0
2.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
260
1.07
0.11
1.0
1.1
u/ml
2.1
0.3
0.38
12
122
(44813793)
10
100
0.87
0.10
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
59
536
0.96
0.10
2.0
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
39
1.12
0.10
2.8
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
228
1.07
0.09
1.7
1.2
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
6
50
1.04
0.08
1.2
1.1
u/ml
3.1
1.9
—
6
40
(40768793) Breast Pathology biopsy report
6
51
1.02
0.08
1.0
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
12
94
1.11
0.07
1.2
1.2
u/ml
1.9
13.7
1.67
12
86
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
137
1.08
0.06
1.5
2.1
iu/l
3.1
6.8
—
7
48
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
273
0.96
0.05
1.3
1.4
mg/l
4.6
3.5
0.26
19
158
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
181
1.06
0.05
1.4
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
131
0.93
0.04
1.2
1.2
—
0.2
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
184
0.95
0.04
1.9
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
182
1.05
0.04
1.4
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
58
517
0.98
0.04
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
58
517
0.98
0.04
1.6
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
52
464
0.97
0.04
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
58
516
0.98
0.03
1.6
1.4
—
—
—
0
0
(4034850)
12
97
1.08
0.03
11.4
5.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
355
3106
0.99
0.03
2.0
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
58
514
0.98
0.02
1.6
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
25
225
0.97
0.02
1.6
1.6
iu/ml
0.0
0.1
—
8
56
(3041096) Erythrocytes [Presence] in Urine by Automated
170
1470
1.01
0.02
3.5
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
342
1.02
0.01
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
37
316
1.02
0.01
1.1
1.1
u/ml
14.1
7.6
0.54
20
183
(40768443) Skin Pathology biopsy report
16
145
0.96
0.01
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
90
790
0.99
0.01
2.5
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
186
1.03
0.01
1.4
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
127
0.96
0.00
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
95
1.01
0.00
1.9
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
306
1.00
0.00
1.9
2.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
90
781
1.00
0.00
2.8
2.3
u/l
8750.5
6826.3
0.11
32
293
(3000330) Specific gravity of Urine by Test strip
20
177
0.98
0.00
3.2
2.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
89
0.98
0.00
1.9
1.3
nmol/l
25.8
33.1
—
10
80
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
8.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
5
51
0.85
0.00
1.0
1.1
u/ml
0.4
2.0
—
5
41
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
15.0
—
0
7
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT – Lack of expected normal physiological development
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).